Case number 1:23-cv-00392
Bristol-Myers Squibb Company et al v. Biocon Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 21, 2023 | 13 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 06/21/2023) (3) |
| Jun 20, 2023 | 12 | STIPULATION of Dismissal by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/20/2023) (2) |
| Jun 9, 2023 | 9 | ANSWER to 1 Complaint with Additional Defenses by Biocon Pharma Limited.(Taylor, Daniel) (Entered: 06/09/2023) (6) |
| Jun 9, 2023 | 10 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Biocon Pharma Limited. (Taylor, Daniel) (Entered: 06/09/2023) (1) |
| Jun 9, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff - filed by Biocon Pharma Limited. (Taylor, Daniel) (Entered: 06/09/2023) (3) |
| Apr 25, 2023 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Heather M. Petruzzi, Madeleine Laupheimer, and Andrew J. Danford - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 04/25/2023) (6) |
| Apr 12, 2023 | 7 | WAIVER OF SERVICE returned executed by Bristol-Myers Squibb Company, Pfizer Inc.: For Biocon Pharma Limited waiver sent on 4/10/2023, answer due 6/9/2023. (Farnan, Michael) (Entered: 04/12/2023) (1) |
| Apr 6, 2023 | 1 | Complaint* (1) |
| Apr 6, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 04/10/2023) (3) |
| Apr 6, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/24/2023. Date of Expiration of Patent: 2/24/2031.Thirty Month Stay Deadline: 8/24/2025. (apk) (Entered: 04/10/2023) (1) |
| Apr 6, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,326,945 B2. (apk) (Entered: 04/10/2023) (1) |
| Apr 6, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company, Pfizer Inc. (apk) (Entered: 04/10/2023) (1) |
| Apr 6, 2023 | 6 | Summons Issued as to Biocon Pharma Limited on 4/6/2023. (apk) (Entered: 04/10/2023) (2) |
